Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315145 · ClinicalTrials.gov registry record · NA
MiDAS III (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study
A NA study, sponsored by Vertos Medical.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT01315145: Completed NA study, sponsored by Vertos Medical.
NCT01315145 is a NA study that has completed, run by Vertos Medical. The registered enrollment target is 138 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01315145, a NA study, has completed, sponsored by Vertos Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, observational clinical study to compare patient outcomes following treatment with either the mild® procedure or epidural steroid injection in patients with moderate to severe lumbar spinal stenosis exhibiting neurogenic claudication.
Primary Outcome
The primary endpoint for evaluating effectiveness will be the proportion of subjects in each group achieving at least a 2-point improvement from baseline in the Visual Analog Scale.
Interventions
- DRUG Epidural Steroid Injection
- PROCEDURE Percutaneous Lumbar Decompression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01315145 record still lists
NCT01315145 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Epidural Steroid Injection is the first listed.
NCT01315145 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01315145 about?
NCT01315145 is a clinical study titled "MiDAS III (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study". This is a multi-center, prospective, observational clinical study to compare patient outcomes following treatment with either the mild® procedure or epidural steroid injection in patients with moderate to severe lumbar spinal stenosis exhibiting neurogenic claudication.
What is the current status of trial NCT01315145?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2011-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01315145?
The interventions under investigation include: Epidural Steroid Injection (DRUG), Percutaneous Lumbar Decompression (PROCEDURE).
Who is sponsoring clinical trial NCT01315145?
This trial is sponsored by Vertos Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01315145's enrollment target sits among peer trials
138 720th of 2000 higher than 1,279 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia